Artigo Acesso aberto Produção Nacional Revisado por pares

Latin American Consensus on management of residual cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic Risk (ALALIP) endorsed by the Inter-American Society of Cardiology (IASC), the International Atherosclerosis Society (IAS), and the Pan-American College of Endothelium (PACE)

2021; Elsevier BV; Volume: 92; Issue: 1 Linguagem: Inglês

10.24875/acm.21000005

ISSN

1405-9940

Autores

Carlos I. Ponte‐Negretti, Fernando Wyss, Daniel Piskorz, Raúl D. Santos, R. Villar, Alberto J. Lorenzatti, Patricio López‐Jaramillo, Peter P. Tóth, Anastassia Amaro, Alfonso K. Rodrigo, Fernando Laņas, Miguel Urina‐Triana, Jofre Lara, T. Osiris Valdés, José Gómez-Mancebo, Alfonso Bryce, Leonardo Cobos S., Adriana Puente-Barragán, Vladimir E. Ullauri-Solórzano, Félix Medina-Palomino, Alfredo Lozada, Maritza Durán, Percy Berrospi, David Miranda, Juan J. Badimón, Jacob González, Peter Libby,

Tópico(s)

Diabetes, Cardiovascular Risks, and Lipoproteins

Resumo

Hypertension, hyperglycemia, dyslipidemia, overweight, obesity, and tobacco (smoking, chewing, and vaping), together with a pro-inflammatory and procoagulant state, are the main risk factors related to atherosclerotic cardiovascular disease.

Referência(s)